Skip to Main Content
May 20, 2022
Health Law Weekly

Featured Articles

House Committee Approves Measure to Reauthorize FDA User Fees

How Is Public Law 116-321 Impacting OCR Investigations?

Current Topics

Behavioral Health

House Energy and Commerce Committee Advances Mental Health Reauthorization Measure

SAMHSA Announces $1.5 Billion for State Opioid Response Grant Program

SAMHSA Announces Funding for Three New Behavioral Health Centers of Excellence

Coronavirus Pandemic Hub

FDA Authorizes First Non-Prescription COVID Test for Multiple Respiratory Viruses

Cybersecurity Hub

U.S. Court in New York Dismisses Claims Based on Alleged Security Breach

Fraud and Compliance

DOJ Files FCA Action Against Medical Device Maker, Owner

Florida Pharmacy Owners Sentenced for Roles in Multi-Million-Dollar Telemedicine Fraud Scheme

Ohio Physician Charged in $8.4 Million Medicare Billing Scheme

Oklahoma Hospital Pays $1.1 Million to Resolve FCA Allegations

Orthotic Brace Suppliers Convicted in $6.5 Million Fraud, Kickback Scheme

Supreme Court Asks U.S. to Weigh in on Particularity Standard in FCA Action

U.S. Court in Maryland Again Rejects Whistleblower Action Alleging Kickback Scheme

University of Maryland Shore Regional Health to Pay $296,870 to Resolve Allegations of Improper Billing

Government Reimbursement

U.S. Court in DC Nixes Medicaid Rule Requiring Drug Makers to Count Certain Patient Assistance in “Best Price” Reporting

Health Insurance

Private Plans Pay Substantially More for Hospital Care Than Medicare, RAND Reports

Health Policy and Administration

U.S. Court in North Dakota Grants Religious Employer Group Preliminary Injunction in Challenge over Gender Transition Care Coverage

Life Sciences

FDA Finalizes Guidance for Drug Labeling to Minimize Medication Errors

FDA Provides Draft Guidance on Risk Management Plans for Preventing Drug Shortages

House Panel Clears Measure to Establish Independent Federal Research Agency
Current Issue
Health Law Weekly Issue - May 20, 2022